JPMorgan Chase & Co. Issues Positive Forecast for Cellebrite DI (NASDAQ:CLBT) Stock Price

Cellebrite DI (NASDAQ:CLBT) had its price objective increased by JPMorgan Chase & Co. from $24.00 to $28.00 in a report issued on Tuesday,Benzinga reports. They currently have an overweight rating on the stock.

CLBT has been the subject of several other research reports. Craig Hallum boosted their price target on Cellebrite DI from $23.00 to $24.00 and gave the company a “buy” rating in a research note on Thursday, November 7th. Needham & Company LLC upped their target price on Cellebrite DI from $21.00 to $28.00 and gave the stock a “buy” rating in a research report on Wednesday, January 22nd. Eight research analysts have rated the stock with a buy rating, According to MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of $22.14.

Cellebrite DI Stock Performance

Shares of NASDAQ CLBT opened at $24.20 on Tuesday. The stock has a market cap of $4.98 billion, a price-to-earnings ratio of -15.61, a PEG ratio of 3.72 and a beta of 1.47. The business has a 50 day simple moving average of $22.41 and a 200 day simple moving average of $18.97. Cellebrite DI has a 52 week low of $8.91 and a 52 week high of $26.30.

Institutional Investors Weigh In On Cellebrite DI

Several hedge funds have recently modified their holdings of the business. LPL Financial LLC raised its stake in shares of Cellebrite DI by 39.0% in the fourth quarter. LPL Financial LLC now owns 54,402 shares of the company’s stock valued at $1,198,000 after purchasing an additional 15,267 shares in the last quarter. Fox Run Management L.L.C. raised its stake in shares of Cellebrite DI by 8.2% in the fourth quarter. Fox Run Management L.L.C. now owns 34,334 shares of the company’s stock valued at $756,000 after purchasing an additional 2,598 shares in the last quarter. KLP Kapitalforvaltning AS acquired a new position in Cellebrite DI during the fourth quarter worth $308,000. Sei Investments Co. raised its stake in Cellebrite DI by 43.9% during the fourth quarter. Sei Investments Co. now owns 408,043 shares of the company’s stock worth $8,989,000 after acquiring an additional 124,558 shares in the last quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its stake in Cellebrite DI by 9.7% during the fourth quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 190,012 shares of the company’s stock worth $4,186,000 after acquiring an additional 16,792 shares in the last quarter. 45.88% of the stock is owned by institutional investors.

Cellebrite DI Company Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.